Winmark director awarded 356 stock options

Q: When do Amy C. Becker’s newly granted WINMARK CORP options vest and expire?

The new options begin to be exercisable on June 1, 2027 and expire on June 1, 2036. A footnote explains they vest 25% per year for four years, typical for time-based director compensation grants.

WINMARK CORP director Amy C. Becker reported a new stock option grant and updated her existing option holdings.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

WINMARK CORP director Amy C. Becker reported a new stock option grant and updated her existing option holdings. On 2026-06-01, she received a non-employee stock option covering 356 shares of common stock at an exercise price of $378.57 per share. The option becomes exercisable starting 2027-06-01 and expires on 2036-06-01, and a footnote states it vests 25% per year for four years.

The filing also lists previously granted non-employee stock options she continues to hold, including grants exercisable at $248.64 for 5,500 underlying shares expiring on 2032-11-15, and at $238.60 for 620 underlying shares expiring on 2032-12-12. The transactions disclosed are compensation-related option awards and holdings, with no open‑market purchases or sales of common stock reported.

Insider Trade Summary

Grant/Award: 356 shares

Grant/Award 9 txns

Insider Becker Amy C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Non-Employee Stock Option (right to buy)	356	$378.57	$135K
holding	Non-Employee Stock Option (right to buy)	--	--	--
holding	Non-Employee Stock Option (right to buy)	--	--	--
holding	Non-Employee Stock Option (right to buy)	--	--	--
holding	Non-Employee Stock Option (right to buy)	--	--	--
holding	Non-Employee Stock Option (right to buy)	--	--	--
holding	Non-Employee Stock Option (right to buy)	--	--	--
holding	Non-Employee Stock Option (right to buy)	--	--	--
holding	Non-Employee Stock Option (right to buy)	--	--	--

Holdings After Transaction: Non-Employee Stock Option (right to buy) — 8,232 contracts for 7,876 underlying shares (Direct)

Footnotes (1)

F1. 25% per year for four years.

Key Figures

New option grant: 356 options New option exercise price: $378.57 per share New option expiration: 2036-06-01 +4 more

7 metrics

New option grant 356 options Non-employee stock option granted on 2026-06-01

New option exercise price $378.57 per share Exercise price for 356-share option grant

New option expiration 2036-06-01 Expiration date of new option grant

Large prior grant 5,500 options Underlying shares at $248.64, expiring 2032-11-15

Prior grant exercise price $248.64 per share Exercise price for 5,500-share option grant

Additional prior grant 620 options Underlying shares at $238.60, expiring 2032-12-12

Additional grant exercise price $238.60 per share Exercise price for 620-share option grant

Key Terms

Non-Employee Stock Option (right to buy), exercise price, expiration date, underlying security shares, +1 more

5 terms

Non-Employee Stock Option (right to buy) financial

"Security title is listed as Non-Employee Stock Option (right to buy)."

exercise price financial

"Conversion or exercise price values such as 378.5700 and 248.6400 are disclosed."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"Each option grant includes an expiration date, for example 2036-06-01 and 2032-11-15."

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

underlying security shares financial

"The filing lists underlying security shares, such as 356.0000 and 5500.0000."

Grant, award, or other acquisition financial

"The transaction code description for the new option is Grant, award, or other acquisition."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did WINMARK CORP (WINA) director Amy C. Becker report in this Form 4?

Amy C. Becker reported a new non-employee stock option grant and updated her option holdings. The filing shows a 356-share option award plus several previously granted options that remain outstanding with different exercise prices and expiration dates.

How many WINMARK CORP options were granted to Amy C. Becker and at what price?

She was granted options on 356 shares of WINMARK CORP common stock at an exercise price of $378.57 per share. These options are classified as a non-employee stock option (right to buy) and represent a compensation-related award.

When do Amy C. Becker’s newly granted WINMARK CORP options vest and expire?

The new options begin to be exercisable on June 1, 2027 and expire on June 1, 2036. A footnote explains they vest 25% per year for four years, typical for time-based director compensation grants.

Does this WINMARK CORP Form 4 show any stock being bought or sold on the market?

No open-market purchases or sales are reported. The Form 4 shows a grant of non-employee stock options and multiple option holdings. All transactions relate to derivative securities rather than direct trading of WINMARK common shares.

What other WINMARK CORP option grants does Amy C. Becker hold according to this filing?

She holds several prior non-employee stock option grants, including options exercisable at $248.64 for 5,500 underlying shares and at $238.60 for 620 underlying shares. These options have expiration dates in 2032 and remain outstanding.

Is Amy C. Becker’s Form 4 activity a routine director compensation event for WINMARK CORP?

The filing describes a grant classified as a non-employee stock option with vesting of 25% per year for four years. This pattern is consistent with routine director equity compensation rather than discretionary open‑market trading activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/01/2026 - 05:56 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Becker Amy C

(Last)

(First)

(Middle)

605 HIGHWAY 169 N, SUITE 400

(Street)

MINNEAPOLIS

MINNESOTA

55441

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
WINMARK CORP [ WINA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-Employee Stock Option (right to buy)	$378.57	06/01/2026		A		356		06/01/2027⁽¹⁾	06/01/2036	Common Stock	356	$378.57	356	D
Non-Employee Stock Option (right to buy)	$248.64							11/15/2023⁽¹⁾	11/15/2032	Common Stock	5,500		5,500	D
Non-Employee Stock Option (right to buy)	$238.6							12/12/2023⁽¹⁾	12/12/2032	Common Stock	620		620	D
Non-Employee Stock Option (right to buy)	$325.99							06/01/2024⁽¹⁾	06/01/2033	Common Stock	380		380	D
Non-Employee Stock Option (right to buy)	$446.68							12/11/2024⁽¹⁾	12/11/2033	Common Stock	240		240	D
Non-Employee Stock Option (right to buy)	$355.9							06/01/2025⁽¹⁾	06/01/2034	Common Stock	300		300	D
Non-Employee Stock Option (right to buy)	$400.97							12/09/2025⁽¹⁾	12/09/2034	Common Stock	300		300	D
Non-Employee Stock Option (right to buy)	$424.82							06/01/2026⁽¹⁾	06/01/2035	Common Stock	280		280	D
Non-Employee Stock Option (right to buy)	$444.54							12/15/2026⁽¹⁾	12/15/2035	Common Stock	256		256	D

Explanation of Responses:

1. 25% per year for four years.

	/s/ Amy C. Becker	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR